Fremont, Calif.-Verseon Corporation announced that during the Annual General Meeting held on November 5, 2018, the company announced to shareholders that Xavier Rolet and Sangtae Kim are joining the board as non-executive directors of Verseon, subject to the completion of normal and customary regulatory diligence. The company reports that Robert Karr and Grover Wickersham have stepped down from the board. Xavier Rolet has broad leadership experience in the global financial community. Xavier Rolet has broad leadership experience in the global financial community. Most recently, he was the CEO of the London Stock Exchange Group (LSEG) from May 2009 to December 2017. Sangtae Kim is a former VP of Lilly Research Laboratories, a division of Eli Lilly, and a former VP at Parke-Davis Pharmaceutical Research. Sangtae is the founding director of the National Science Foundation Division of Shared Cyber infrastructure and a former Executive Director of the Morgridge Institute for Research.